Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Acta Medical and Health Sciences (AMHS)
Pratiwi, Siska T
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
The duration of Mediterranean diet affects the levels of the lipid profile in dyslipidemia patients Handayani, Dewi R; Septiadi, Endry; Inayati, Iis; Pratiwi, Siska T; Anugrah, Rifal A; Rohman, Nur M; Prawira, Achmad H; Rais, Muhammad A
ACTA Medical Health Sciences Vol. 1 No. 2 (2022): ACTA Medical Health Sciences
Publisher : ACTA Medical Health Sciences

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (290.488 KB)

Abstract

Dyslipidemia is a lipid metabolism disorder that indicates abnormal levels of lipid profile in plasma. The most notable lipid profile abnormalities include increased levels of total cholesterol, low-density lipoprotein cholesterol (LDL), triglycerides, and a decrease in high-density lipoprotein cholesterol (HDL). One of the non-pharmacological management for dyslipidemia is diet modification with the Mediterranean diet. This study aims to determine the relationship between the duration of the Mediterranean diet and lipid profile levels in Prolanis patients who experience dyslipidemia in a clinic in Bandung. The research method was analytical with cohort observations. Sampling was done by consecutive sampling. Subjects in this study were 30 dyslipidemic patients who followed a Mediterranean diet and were examined for lipid profile levels in the first and third months. Data on total cholesterol, LDL, HDL, and triglycerides were analyzed using the T-dependent test. Total cholesterol and Triglycerides decreased significantly, and HDL increased significantly in the first and third month. The duration of the Mediterranean diet shows a reduction effect of total cholesterol, LDL, triglycerides and significantly increase HDL in patients with dyslipidemia because the recommended foods are high in monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), which can correct abnormalities in lipid profile levels. DOI : 10.35990/amhs.v1n2.p64-70 REFERENCES Anwar TB. Dislipidemia Sebagai Faktor Resiko Penyakit Jantung Koroner. 2006;1–10. Wahjuni S. Dislipidemia menyebabkan stres oksidatif ditandai oleh meningkatnya malondialdehid. Bali: Universitas Udayana; 2015. hlm. 1–109. Hamam F. Dyslipidemia and related risk factors in a Saudi university community. Food Nutr Sci. 2017;8(1):56–69. Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. Riset Kesehatan Dasar (RISKESDAS). Jakarta: Kemenkes RI; 2013. Labibah Z, Anggraini DI. Diet Mediterania dan manfaatnya terhadap kesehatan jantung dan kardiovaskular. J Majority. 2016;5:1–3. Estruch R. Anti-inflammatory effects of the Mediterranean diet: The experience of the PREDIMED study. Proc Nutr Soc. 2010;69:333–340. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean diet and health. Ann Ist Super Sanita. 2013;39:335–342. Tuttolomondo A, Simonetta I, Handayani DR, Daidone M, Mogavero A, Ortello A, Pinto A. Metabolic and vascular effects of the Mediterranean diet. Int J Mol Sci. 2019;20(19). John MF, Adam. Dislipidemia. Dalam: Sudoyo AW, dkk, editor. Buku Ajar Ilmu Penyakit Dalam. Jilid III, Edisi IV. Jakarta: Balai Penerbit FKUI; 2006. hlm. 2556–2557. Wiyono P. Penatalaksanaan dislipidemia pada diabetes melitus. 2003;1–11. Corradi PF, Agrawal N, Gumaste N, Goldberg IJ. Principles of Diabetes Mellitus. Principles of Diabetes Mellitus. 2016;1–19. Anneke R, Sulistiyaningsih. Review: Terapi herbal sebagai alternatif pengobatan dislipidemia. Farmaka. 2018;16:213–221. Rhee E, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. 2018 Guidelines for the management of dyslipidemia and cardiovascular disease in Koreans. Korean J Intern Med. 2019;34(4):723–771. Lestari A, Handini MC, Sinaga TR. Faktor risiko kejadian dislipidemia pada lansia (Studi kasus kontrol pada lansia di Poli Lansia RSUD Bangkinang Kabupaten Kampar Tahun 2016–2017). J Ris Hesti Medan Akper Kesdam I/BB Medan. 2018;3(2):16. Steinberg D, Witztum JL. History of discovery: Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(12):2311–2316. Tautik S. Hubungan antara kadar estradiol dengan profil lipid. 2011;1:47. Nugraheni K. Pengaruh pemberian minyak zaitun ekstra virgin terhadap profil lipid serum tikus putih strain Sprague Dawley hiperkolesterolemia. J Ilmu Gizi. 2012;1:27. Mekki K, Bouzidi BN, Kaddous A, Bouchenak M. Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients. 2010;1:110–115. Pachyrrhizus B, Pada E, No JS. J Nutr College. 2014;3:573–579. Make Each Day Mediterranean. U.S. News and World Report; 2012. hlm. 1–11. Dernini S, Berry EM, La Vecchia C, Capone R. MedDiet4.0: The Mediterranean diet with four sustainable benefits. Public Health Nutr. 2016;20(7):1322–1330. Boucher JL. Mediterranean eating pattern. Diabetes Spectrum. 2017;72–76. American Diabetes Association. Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015;128(3):229–238. Nutrition Clinics for UW Medical Foundation. Mediterranean Food Guide. UW Health; 2019. hlm. 1–42. Meslier V, Laiola M, Roager HM, De Filippis F, Roume H, Quinquis B, et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 2020;69(7):1258–1266.
Clinical and laboratory manifestations of dengue fever cases at subang regional general hospital Sulthan, Rifky R; Ayukarningsih, Yoke; Pratiwi, Siska T; Rosifah, Diana
ACTA Medical Health Sciences Vol. 4 No. 2 (2025): Acta Medical and Health Sciences
Publisher : ACTA Medical Health Sciences

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Dengue fever remains a major public health problem in Indonesia, particularly among children. Early recognition of clinical manifestations, supported by laboratory findings, is crucial for diagnosis, monitoring disease progression, and preventing severe complications. This study aimed to describe the clinical manifestations and laboratory findings of dengue fever cases in children. A cross-sectional study design was used, based on medical records of all pediatric patients aged 0–18 years who werediagnosed with dengue infection at Subang Regional Hospital from January to December 2024. Total sampling yielded 197 cases that met the inclusion criteria. Most patients were aged 6–18 years (73.1%) and male (57.4%). The highest incidence occurred in March (20.8%). The most common clinical manifestations were fever (100%), abdominal pain (61.9%), nausea (61.4%), vomiting (53.8%), and headache (37.1%). Warning signs were identified in 46.2% of patients, with persistent vomiting and abdominal pain being the most frequent. Laboratory findings showed thrombocytopenia (75.0%) and leukopenia (62.5%), particularly in the 6–18 age group, while anemia was most common in infants aged 0–1 year (92.3%). Serological examinations showed all patients were NS1 positive at initial testing, with IgM and IgG detected in subsequent examinations, indicating progression from the acute to the convalescent phase. These findings highlight the importance of integrated clinical and laboratory evaluation for early detection and appropriate management of dengue fever.   DOI : 10.35990/amhs.v4n2.p77-86   REFERENCES Syamsir, Daramusseng A. Analisis spasial efektivitas fogging di wilayah kerja Puskesmas Makroman, Kota Samarinda. JNIK. 2018;1(2):1–7. Podung GCD, Tatura SNN, Mantik MFJ. Faktor risiko terjadinya sindroma syok dengue pada demam berdarah dengue. JBM. 2021;13(2):161–166. Ubaidillah, Kurniawan D. Faktor risiko yang mempengaruhi terjadinya kejadian demam berdarah dengue (DBD) di Puskesmas Sewon II Bantul. PHJ. 2020;11(1):7–12. Rahma FA, Rahayu DFS, Prawira LY, Nandini M, Bariyah RA. Faktor risiko aspek lingkungan dan aspek perilaku terhadap kejadian demam berdarah dengue (DBD) di wilayah kerja Puskesmas Sukmajaya, Kota Depok tahun 2022. JoPHJ. 2023;2(3):91–101. Sumampouw OJ. Epidemiologi demam berdarah dengue di Kabupaten Minahasa, Sulawesi Utara. SRJPH. 2020;1(1):1–8. Nanda M, Saragih PA, Nasution DH, Daulay A, Sari DP, Ridho NU. Analisis pengendalian faktor risiko dan vektor kejadian demam berdarah dengue. FJIK. 2023;2(2):111–116. Anggraini DR, Huda S, Agushybana F. Faktor perilaku dengan kejadian demam berdarah dengue (DBD) di daerah endemis Kota Semarang. JIKK. 2021;12(2):344–349. World Health Organization (WHO). Disease outbreak news: Dengue—Global [Internet]. 2024 [diakses 2 Apr 2025]. Tersedia pada: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON518 World Health Organization (WHO). Dengue Bulletin [Internet]. 2021 Mar [diakses 2 Apr 2025]. Tersedia pada: https://www.who.int/publications/i/item/ISSN0250-8362 Tansil MG, Rampengan NH, Wilar R. Faktor risiko terjadinya kejadian demam berdarah dengue pada anak. JBM. 2021;13(1):90–99. Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia (SKI) dalam angka: data akurat, kebijakan tepat [Internet]. 2023 [diakses 7 Jan 2025]. Tersedia pada: https://kemkes.go.id/id/survei-kesehatan-indonesia-ski-2023 Wila RW, Nusa R. Gambaran klinis dan respon imun penderita demam berdarah dengue di Rumah Sakit Kristen Lindi Mara Sumba Timur selama bulan Januari sampai dengan Desember 2018. BALABA. 2020;16(2):209–216. Indriyani DPR, Gustawan IW. Manifestasi klinis dan penanganan demam berdarah dengue grade 1: sebuah tinjauan pustaka. ISM. 2020;11(3):1015–1019. Ahmad ZF, Mongilong NS, Kadir L, Nurdin SSI, Moo DR. Perbandingan manifestasi klinis penderita demam berdarah. IJPE. 2023;3(1):143–153. Dahlan MS. Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan. In: Suslia A, editor. Edisi ke-3. Jakarta: Salemba Medika; 2010. p. 155–157. Kementerian Kesehatan Republik Indonesia. Pedoman nasional pelayanan kedokteran: tata laksana infeksi dengue anak dan remaja [Internet]. Indonesia: Kemenkes RI; 2021 May 3. Tersedia pada: https://kemkes.go.id/id/pnpk-2021-infeksi-dengue-anak-dan-remaja Prayitno A, Taurel AF, Nealon J, Satari HI, Karyanti MR, Sekartini R, et al. Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children. PLoS Neglected Tropical Diseases. 2017;11(6). Khan MAS, Al Mosabbir A, Raheem E, Ahmed A, Rouf RR, Hasan M, et al. Clinical spectrum and predictors of severity of dengue among children in 2019 outbreak: A multicenter hospital-based study in Bangladesh. BMC Pediatrics. 2021;21(1). Burattini MN, Lopez LF, Coutinho FAB, Siqueira JB, Homsani S, Sarti E, et al. Age and regional differences in clinical presentation and risk of hospitalization for dengue in Brazil, 2000–2014. Clinics. 2016;71(8):455–463. Kumar M, Verma R, Nirjhar S, Singh M. Dengue in children and young adults: A cross-sectional study from the western part of Uttar Pradesh. Journal of Family Medicine and Primary Care. 2020;9(1):293. Tchuandom SB, Tchadji JC, Tchouangueu TF, Biloa MZ, Atabonkeng EP, Fumba MIM, et al. A cross-sectional study of acute dengue infection in paediatric clinics in Cameroon. BMC Public Health. 2019;19(1):958. Lee YH, Hsieh YC, Chen CJ, Lin TY, Huang YC. Retrospective seroepidemiology study of dengue virus infection in Taiwan. BMC Infectious Diseases. 2021;21(1). Kesetyaningsih TW. Distribution of dengue hemorrhagic fever (DHF) in regards to age and sex in Sleman, Yogyakarta, Indonesia. 2019. Zohra T, Din M, Ikram A, Bashir A, Jahangir H, Baloch IS, et al. Demographic and clinical features of dengue fever infection in Pakistan: A cross-sectional epidemiological study. Tropical Diseases, Travel Medicine and Vaccines. 2024;10(1). Taufik A, Hasibuan PA, Putri FD, Wulandari A, Mutika WT, Lisa M. Case series: Angka kematian demam berdarah dengue berdasarkan jenis kelamin di Jawa Barat. Jurnal Kesmas Untika Luwuk: Public Health Journal. 2024;15(2):124–133. Setrkraising K, Kittitrakul C. Gastrointestinal manifestations and prognostic factors for severe dengue in Thai children. The American Journal of Tropical Medicine and Hygiene [Internet]. 2024 [diakses 19 Jul 2025];112(3):642–647. Tersedia pada: https://pubmed.ncbi.nlm.nih.gov/39719114/ Afroze S, Shakur S, Wahab A, Shakur S. Clinical profile of dengue and predictors of its severity among children. American Journal of Pediatrics. 2019;5(4):219. Karyanti MR, Uiterwaal CSPM, Hadinegoro SR, Widyahening IS, Saldi SRF, Heesterbeek JAPH, et al. The value of warning signs from the WHO 2009 dengue classification in detecting severe dengue in children. The Pediatric Infectious Disease Journal. 2024;43(7):630–634. Islam S, Khan MAS, Badal MFA, Khan MZI, Gozal D, Hasan MJ. Clinical and hematological profiles of children with dengue residing in a non-endemic zone of Bangladesh. PLoS Neglected Tropical Diseases. 2022;16(10). Bodinayake CK, Tillekeratne LG, Nagahawatte A, Devasiri V, Kodikara Arachchi W, Strouse JJ, et al. Evaluation of the WHO 2009 classification for diagnosis of acute dengue in a large cohort of adults and children in Sri Lanka during a dengue-1 epidemic. PLoS Neglected Tropical Diseases. 2018;12(2). Prieto-Torres AE, Medina-Lozano LJ, Ramírez-Ávila JD, Faccini-Martínez ÁA. Utility of VIDAS® dengue diagnostic assays to differentiate primary and secondary dengue infection: A cross-sectional study in a military hospital from Colombia. Tropical Medicine and Infectious Disease. 2025;10(2). Versiani AF, Kaboré A, Brossault L, Dromenq L, dos Santos TMIL, Milhim BHGA, et al. Performance of VIDAS® diagnostic tests for the automated detection of dengue virus NS1 antigen and of anti-dengue virus IgM and IgG antibodies: A multicentre, international study. Diagnostics. 2023;13(6). Premazzi Papa M, Mendoza-Torres E, Sun P, Encinales L, Goulet J, Defang G, et al. Dengue NS1 antibodies are associated with clearance of viral nonstructural protein-1. Journal of Infectious Diseases. 2024;230(6):e1226–e1234. Anika US, Islam M, Nur Mou FE, Saha M, Deb A, Tui RR, et al. The 2023 dengue outbreak in Bangladesh: Exploring the epidemiology in hospitalized patients. The American Journal of Tropical Medicine and Hygiene. 2024;110(6):1165–1171. Felix AC, Romano CM, Campos Centrone C, Rodrigues CL, Villas-Boas L, Araújo ES, et al. Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010. Clinical and Vaccine Immunology. 2012;19(12):1972–1976.
Co-Authors Anugrah, Rifal A Diana Rosifah, Diana Handayani, Dewi R Inayati, Iis Prawira, Achmad H Rais, Muhammad A Rohman, Nur M Septiadi, Endry Sulthan, Rifky R Yoke Ayukarningsih, Yoke